A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study of VX-770 to Evaluate Safety, Pharmacokinetics, and Biomarkers of CFTR Activity in Cystic Fibrosis (CF) Subjects with Genotype G551D

Femme et Homme

| Pays :
| Organes :
| Spécialités :

Extrait

- Evaluate the safety and tolerability of multiple dose administrations of orally administered VX-770 given to cystic fibrosis (CF) subjects with genotype G551D.

Critère d'inclusion

Cystic fibrosis

Liens

ictrp
euctr